Skip to main content
. 2019 Aug 30;6(9):1858–1871. doi: 10.1002/acn3.50886

Figure 4.

Figure 4

Residual enzymatic ASS1 activity predicts organ‐specific manifestations. (A) Boxplot illustrating presence of movement disorders (%) for individuals with a residual enzymatic ASS1 activity below or equal to 19.3% (n = 34) and above 19.3% (n = 26). Gray shading corresponds to individuals with movement disorders in each group. Recursive partitioning, P = 0.03. (B) Boxplot displaying presence of hepatocellular injury (%) for individuals with a residual enzymatic ASS1 activity below or equal to 3.9% (n = 7) and above 3.9% (n = 48). Gray shading corresponds to individuals with episode(s) of hepatocellular injury in each group. Recursive partitioning, P = 0.039. ASS1, argininosuccinate synthetase 1.